
Empowering Lives ThroughPrecision Preventive Medicine
Join thousands of patients and healthcare providers worldwide who trust Predixa's cutting-edge solution tests for early malignancy detection and prevention.
PredixaNext-generation diagnostics for early disease identification.
Predixa empower clinicians to predict and detect malignancies at their earliest and most treatable stages. Our next-generation solutions are revolutionizing preventive medicine with clinical insights to identify malignancies before symptoms arise.

Predixa Foundation
Predixa is a non-profit foundation committed to early disease detection and prevention through advanced solutions testing.
Our founding team brings together expertise in:
To be the leading reference in personalized and preventive healthcare — anticipating health risks through science and technology, and ensuring accessible solutions that guide people toward longer, healthier lives.
To empower early detection and prevention of diseases through cutting-edge solutions testing and medical innovation, making personalized healthcare accessible to all, and improving quality of life across communities.
Transforming preventive diagnostics
At Predixa, we combine advanced cutting-edge tools to revolutionize early detection and malignancy prediction.
Leadership Excellence
A multidisciplinary team united by a mission to revolutionize precision preventive medicine.
Predixa is led by a multidisciplinary team of seasoned professionals with decades of combined experience across clinical oncology, molecular diagnostics, medical affairs, and healthcare commercialization in Latin America and beyond. Together, they bring deep expertise in pharmaceutical leadership, next-generation sequencing, translational research, and patient access — uniting science, innovation, and strategy to advance precision preventive medicine and bring cutting-edge solutions closer to patients and clinicians.
Get in Touch
Interested in learning more about our genomic testing solutions? Fill out the form below and our team will contact you.
